BrainCheck Secures $13M Series A Financing
2026-02-26
Tweet
AUSTIN, TX, BrainCheck, a digital platform for cognitive assessment and care, today announced that it has raised an additional $13 million in Series A financing.
The round was led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises.
BrainCheck is a clinically validated digital platform for cognitive assessment and care, anchored by BrainCheck Assess™-its flagship FDA Class II digital cognitive assessment. The platform delivers standardized, repeatable cognitive data across clinical and research settings.
BrainCheck is used by more than 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic, as well as 46 research hospitals, including The University of Texas at Austin and Stanford University. Clinicians use BrainCheck's validated screeners and care planning tools to build tailored protocols, with more than 640,000 cognitive assessments and 14,000 Care Plans completed to date.
BrainCheck is a clinically validated digital platform for cognitive assessment and care, anchored by BrainCheck Assess™-its flagship FDA Class II digital cognitive assessment. The platform delivers standardized, repeatable cognitive data across clinical and research settings.
BrainCheck is used by more than 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic, as well as 46 research hospitals, including The University of Texas at Austin and Stanford University. Clinicians use BrainCheck's validated screeners and care planning tools to build tailored protocols, with more than 640,000 cognitive assessments and 14,000 Care Plans completed to date.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
